WPD Pharmaceuticals Inc. (CSE: WBIO)
WBIO trades on the Canadian Securities Exchange in Life Sciences. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for WBIO.CN, last bar 2026-11-13, computed by MarginsX.
Profile
| Field | Value |
|---|---|
| Ticker | WBIO on the Canadian Securities Exchange |
| Yahoo symbol | WBIO.CN |
| Sector | Life Sciences |
| Headquarters | The TMX list gives no head office |
| Listed | The TMX list gives no listing date |
| Listing type | TMX leaves listing type blank for long-listed issuers |
| Shares outstanding | Not on the TMX list |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | No SEC filer matched on exact name with a Canadian address or US interlisting |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | 0.0% |
| 1 week | 0.0% |
| 1 month | 0.0% |
| 3 months | 0.0% |
| 6 months | 0.0% |
| Year to date | 0.0% |
| 1 year | 0.0% |
| From 52-week high | 0.0% |
| 52-week range | C$0.0700 to C$0.0700 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
147 documents in 3 types. Each title links to the document at its source.
Annual financial statements (6)
| Document | Type | Filed |
|---|---|---|
| WPD Announces Filing of Annual Financial Statements and Provides Corporate Update | Annual financial statements | 2024-05-16 |
| WPD Announces Filing of Annual Financial Statements and Provides Corporate Update | Annual financial statements | 2024-01-31 |
| WPD Pharmaceuticals Provides Update on Audited Financial Statements | Annual financial statements | 2021-06-10 |
| WPD Pharmaceuticals Receives Approval for Temporary Management Cease Trade Order For Late Filing of Audited Annual Financial Statements | Annual financial statements | 2021-05-05 |
News release (75)
| Document | Type | Filed |
|---|---|---|
| December 24, 2024 WPD ANNOUNCES RECORD DATE OF SHARE CONSOLIDATION OF COMMON SHARES | News release | 2024-12-24 |
| WPD ANNOUNCES SETTLEMENT OF DEBT FOR COMMON SHARES | News release | 2024-12-05 |
| WPD ANNOUNCES SETTLEMENT OF DEBT FOR COMMON SHARES | News release | 2024-06-07 |
| WPD Pharmaceuticals Sp. z o. o., received the second tranche of the funds | News release | 2023-11-01 |
Other (66)
| Document | Type | Filed |
|---|---|---|
| WPD Pharmaceuticals’ License Partner, Moleculin Biotech to Host Conference Call to Discuss COVID-19 Potential in WP1122 Drug Candidate | Conference call transcript | 2020-04-16 |
| WPD's Polish Subsidiary Signs Investment Agreement with ACRX Investments Limited | Material contract / governance | 2023-09-01 |
| WPD Pharmaceuticals terminates grant agreement with the NCRD for the POIR.01.01.01-00-2382/20-00 project; resignation from the WPD’s Board of… | Material contract / governance | 2022-11-24 |
| WPD Pharmaceuticals Signs Annex to License Agreement with Wake Forest University Health Sciences | Material contract / governance | 2022-05-16 |
Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
Halted: no resumption notice since 2025-05-08 in our data.
| Notice | Action | Reason | Notice |
|---|---|---|---|
| 2025-05-08 8:00 AM ET | Halt | Cease Trade Order | CIRO notice |
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2020-02-11 | Option To Acquire, Security To Be Acquired | US$0 | US$890K | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on exact issuer name. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| NAV | NAVCO Pharmaceuticals Inc. | TSXV | C$285K | 0.0% | 0.0% |
| EVMT | Evome Medical Technologies Inc. | TSXV | C$301K | 0.0% | 0.0% |
| ARC | ARCpoint Inc. | TSXV | C$332K | 0.0% | 0.0% |
| VXL | Vaxil Bio Ltd. | TSXV | C$398K | -24.1% | -35.3% |
| WAVE | Waverley Pharma Inc. | TSXV | C$540K | +100.0% | 0.0% |
The app has the price chart, every filing, private raises and the full peer set for WBIO.
Open in the app